Previous Article | Next Article ![]()
Journal of Bacteriology, October 2003, p. 5755-5764, Vol. 185, No. 19
0021-9193/03/$08.00+0 DOI: 10.1128/JB.185.19.5755-5764.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
Eric S. Boyd,1 Jeremy D. Semrau,3 William E. Antholine,4 J.-I. Han,3 James A. Zahn,2,
Jeffrey M. Boyd,1,
Arlene M. de la Mora,5 and Alan A. DiSpirito1*
Department of Biochemistry, Biophysics, and Molecular Biology,1 Graduate Program in Microbiology,2 Department of Psychology, Iowa State University, Ames, Iowa 50011-3211,5 Department of Civil and Environmental Engineering, The University of Michigan, Ann Arbor, Michigan 48109-2125,3 Biophysics Research Institute, Medical College of Wisconsin, Milwaukee, Wisconsin 532264
Received 24 April 2003/ Accepted 21 July 2003
|
|
|---|
|
|
|---|
0.9 nmol of Cu/mg of cell protein), the sMMO is expressed (20, 28). Cells cultured under higher copper/biomass ratios express pMMO, and there is no detectable sMMO expression (35, 43). While sMMO is a well-characterized enzyme that consists of a hydroxylase component composed of three polypeptides and a hydroxo-bridged binuclear iron clusteran NADH-dependent reductase component composed of one polypeptide containing both FAD and [Fe2S2] cofactors and a regulatory polypeptide (18, 26, 27, 31, 47)information on the molecular properties of pMMO is limited due to the instability of pMMO in cell-free fractions.
Purification of the pMMO has been reported from Methylococcus capsulatus Bath (2, 25, 33, 52) and M. trichosporium OB3b (30, 44). The reporting laboratories agree that pMMO is a copper-containing enzyme composed of three polypeptides with molecular masses of approximately 45,000 (
subunit), 26,000 (ß subunit), and 23,000 Da (
subunit) with an (
ß
)2 molecular structure (15). However, researchers in the field disagree on the number and type of metal centers associated with the pMMO as well as the nature of the physiological electron donor. One model proposes pMMO as an enzyme made up of 10 to 15 Cu atoms and 2 Fe atoms. In this model, two type II copper atoms and two EPR-silent iron atoms are associated with the
ß
complex (52). The remaining 8 to 13 copper atoms are bound to a small, 1,218-Da copper binding peptide/compound (cbc) that copurifies with the pMMO (14, 52). The role of copper-containing cbc (Cu-cbc) is not known; it may be involved in electron flow to the active site or serve a secondary role, such as copper acquisition, maintenance of a particular redox state, protection against oxygen radicals, or serving as a copper chaperone. The second theory proposes a 15- to 21-Cu-atom enzyme in which the coppers are coordinated into 5 to 7 spin-coupled trinuclear copper atom clusters, in which 2 to 3 clusters are catalytic and 3 to 4 clusters are involved in electron transfer from NADH to the catalytic centers (32-34). The third model proposes the pMMO as a 2-Cu-atom and 1- to 2-Fe-atom enzyme (2, 25, 46). The first and third models also propose that the pMMO is linked to the electron transfer chain at the quinone level (2, 11, 13, 25, 52), while the second theory proposes the enzyme utilizes NADH as the physiological reductant (33).
One of the main limitations to all of the models presented above is the use of low-activity preparations in the characterization of this novel enzyme. The reported purified preparations show activities of
17 nmol · min-1 · mg of protein-1, representing 1 to 5% of the physiological rates. Recent attempts by Basu et al. (2) have resulted in partially purified preparations with activities in the range of 50 nmol · min-1 · mg of protein-1, but they were unable to purify an active form of the enzyme. This paper describes an improved purification procedure resulting in purified preparations with activities of >130 nmol · min-1 · mg of protein-1. This report examines the growth conditions resulting in the stabilization of cell-free pMMO activity and the effect of detergent concentration on the metal composition of the pMMO, as well as addressing the issue of the physiological reductant of the pMMO.
|
|
|---|
M. capsulatus Bath cells were cultured to monitor the effect of copper addition during growth as described above with the following modifications. All glassware was acid washed in 0.1 N HNO3, and copper was omitted from the medium in flask cultures as well as in the initial fermentation medium. Culture samples were taken before the addition of copper (0 µM copper) and when the amended copper concentration in the chemostat reached approximately 1, 5, 6, 15, 20, 25, 35, 45, 60, 70, 75, 80, and 95 µM and were subsequently harvested and washed as described above.
Enzyme activity.
MMO activity was determined by the epoxidation of propylene as previously described (12). The reductants used were NADH (7 mM) and/or duroquinol (approximately 30 mM) for cell extracts and formate (2.5 mM) for whole-cell samples. The reduction of duroquinone to duroquinol was performed as described by Shiemke et al. (40). Both the duroquinol and NADH were lyophilized to remove residual ethanol. Following lyophilization, both reductants were checked for the presence of ethanol on a SRI 8610C gas chromatography system (SRI Instruments, Las Vegas, Nev.) equipped with a flame ionization detector and an 8-by-0.085-in. HaySep D column. Additional lyophilization steps were added if ethanol was detected. In reaction mixtures containing NADH dehydrogenase (NDH), approximately 12 µg of NDH, which would reduce 1 µmol of duroquinone · min-1 (10), was added. For optimal propylene oxidation rates, 0.4 ± 0.2 mol of Cu per mol of
ß
pMMO subunit was added to reaction mixtures containing purified pMMO or purified NDH-pMMO complex. The exact concentration of copper added was determined empirically for each sample. All reactions were initiated by the addition of 2 ml of propylene and 2 ml of air. Reaction mixtures were incubated at 42°C on a rotary shaker at 250 rpm. In addition to propylene oxidation activity in the soluble fraction, sMMO activity was monitored by the formation of naphthol from naphthalene as described by Brusseau et al. (6).
Isolation of membranes and soluble fractions. All manipulations were performed at 4°C under anaerobic conditions (95% argon and 5% hydrogen [vol/vol]). DNase I (1 µg/ml) was added to the washed cell suspension and then deoxygenated by 3 to 5 cycles of vacuum followed by purging with oxygen-free argon. Prepared cells were lysed with three passes on a constant-flow French pressure cell at 18,000 lb/in2. The cell lysate was centrifuged at 14,000 x g for 15 min to remove unlysed cells and cell debris. The supernatant was taken and centrifuged at 150,000 x g for 1 h to sediment membranes. The membranes were resuspended using a Dounce homogenizer in a mixture containing 30 mM MOPS (pH 7.3), 1 M KCl, and 1 mM benzamidine buffer and centrifuged for 1 h at 150,000 x g. The washed membrane pellet was resuspended in a minimal volume of 30 mM MOPS (pH 7.3)-1 mM benzamidine buffer.
Solubilization of pMMO. A 10% (wt/vol) solution of dodecyl ß-D-maltoside was added to the washed membrane fraction to final concentrations of 0.25, 0.5, 0.75 1.0, 1.25, 1.5, 1.75, 2.0, 3.0, and 4.0 g of dodecyl ß-D-maltoside per g of protein, and this mixture was stirred for 1 h and then centrifuged at 150,000 x g for 1 h at 4°C. Propylene oxidation activity was determined before centrifugation and in the particulate and soluble fractions following centrifugation.
Purification of pMMO, NDH, and NDH-pMMO complex. The detergent-solubilized fraction following centrifugation of the suspension of 1.2 g of dodecyl ß-D-maltoside per g of membrane protein was loaded on a 5.0- by 7-cm DEAE-Sepharose Fast Flow (FF) column equilibrated with buffer containing 30 mM MOPS (pH 7.3), 1 mM benzamidine, and 0.1% dodecyl-ß-D-maltoside. The column was washed with buffer containing 30 mM MOPS (pH 7.3), 100 mM KCl, 1 mM benzamidine, and 0.1% dodecyl-ß-D-maltoside. The NDH-pMMO complex remained bound to the column and eluted with buffer containing 30 mM MOPS (pH 7.3), 250 mM KCl, 1 mM benzamidine, and 0.1% dodecyl-ß-D-maltoside. For separation of NDH and pMMO, samples from the DEAE-Sepharose FF column were diluted with an equal volume of buffer containing 30 mM MOPS (pH 7.3), 1 mM benzamidine, and 0.1% dodecyl-ß-D-maltoside and loaded onto a 2.6- by 20-cm DEAE-Sepharose FF column equilibrated with buffer containing 30 mM MOPS (pH 7.3), 125 mM KCl, 1 mM benzamidine, and 0.1% dodecyl-ß-D-maltoside. The loaded column was washed with 1 column volume of buffer containing 30 mM MOPS (pH 7.3), 125 mM KCl, 1 mM benzamidine, and 0.1% dodecyl-ß-D-maltoside and eluted with buffer containing 30 mM MOPS (pH 7.3), 250 mM KCl, 1 mM benzamidine, and 0.1% dodecyl-ß-D-maltoside. The fraction containing pMMO was then concentrated under nitrogen gas (99.99%) by ultrafiltration with a YM-50 filter (Millipore Corp., Bedford, Mass.). NDH was also isolated as previously described by Cook and Shiemke (10).
Dodecyl ß-D maltoside treatment of pMMO. The dodecyl ß-D-maltoside concentration in purified pMMO samples was increased to 0.1, 0.2, 0.3, 0.4, or 0.5 mg/mg of protein. The samples were then incubated under anaerobic conditions for 30 min and applied to a 2.6- by 55-cm Superdex 30 column equilibrated with buffer containing 30 mM MOPS (pH 7.3), 1 mM benzamidine, and 0.1% dodecyl-ß-D-maltoside. The pMMO samples were collected from the void volume, and Cu-cbc was collected from the included volume.
Electrophoresis and immunoblot analysis. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) was performed on precast 10 or 12% Bis-Tris gels with MOPS or on precast 10 or 12% 2-(morpholino) ethanesulfonic acid (MES)-SDS running buffer as specified by the manufacturer (Invitrogen, Carlsbad, Calif.), or SDS-PAGE was performed by the method of Laemmli (22). Gels were stained for total protein with Coomassie brilliant blue R or blotted for immunoassays. Densitometry was performed with a Bioimaging Technologies Biovideo MP1000 gel documentation system.
Proteins were blotted onto polyvinylidene difluoride Plus transfer membranes (Micron Separations, Inc., Westboro, Mass.) using an Xcell II Blot Module (Invirogen) according to manufacturer's specifications unless otherwise noted. For transfer of the
subunit of pMMO, the concentration of methanol in the transfer buffer was reduced to 5% and the concentration of SDS was increased to 0.02%. The transfer time for the
subunit of pMMO was 90 min at 30 V, while the transfer time for the ß and
subunits was 60 min at 30 V. Following treatment with serum raised against purified protein, antibodies were detected with the Opti-4CN substrate kit according to the manufacturer (Bio-Rad Laboratories, Hercules, Calif.).
Preparation of antibodies against the pMMO. Antiserum against pMMO was raised in one New Zealand White rabbit by Animal Pharm Services, Inc., (Healdsburg, Calif.). Immunoglobin G was purified from the serum by using a protein A Sepharose CL-4B column as specified by manufacturer (Amersham Biosciences Corp., Piscataway, N.J.).
Protein, cell enumeration, and metal determinations. Samples were assayed for protein by the method of Lowry et al. (29) using bovine serum albumin as a standard. Cells were enumerated on a Beckman Coulter Epics XL Flow Cytometer (Beckman Coulter, Inc., Allendale, N.J.).
Sample preparations for metal analysis were determined as previously described (52) and analyzed for copper or iron either by inductively coupled plasma atomic emission-mass spectroscopy (ICP-MS) with a model 4500 ICP-MS (Hewlett-Packard, St. Paul, Minn.) or with a Perkin-Elmer 1100B atomic absorption spectrophometer (Sheldon, Conn.).
The percentage of copper bound to cbc in the spent medium was determined by the ratio of copper that bound to a Dianion HP-20 column (Supelco, Bellefonte, Pa.) versus the copper in the void volume from the Dianion HP-20 column. The spent medium was loaded onto a 1.5- by 7-, 2- by 11-, or a 7- by 20-cm Diaion HP-20 column, depending on the sample size. The column was washed with 2 column volumes of H2O, and the organic phase was eluted from the Dianion HP-20 columns with 50% methanol-50% acetonitrile (vol/vol). The organic phase consisted of approximately 80% cbc, 12% protoheme IX, and 8% trace proteins and pyrroloquinoline quinone. The eluant containing the cbc fraction was rotary evaporated at 50°C, freeze-dried, and resuspended in 2 mM ammonium phosphate buffer (pH 7.0). For the percentage of copper bound to cbc, the concentration of copper was determined in the spent medium, in the void volume from the Dianion HP-20 column (soluble copper), and in the fraction that bound to the Dianion HP-20 column (copper bound to cbc).
Superoxide dismutase assay. Superoxide anion radicals were generated using phenazine methosulfate and NADH as previously described (38). Generation of superoxide anion was monitored by observing the reduction of nitroblue tetrazolium to blue formazan at 560 nm (4, 7, 38).
Fatty acid analysis. Whole-cell samples were normalized to two different protein concentrations (1.8 and 3.6 mg of protein per ml) for each cell suspension. The cell suspensions were saponified, methylated, and extracted by the methods described by MIDI Corp. (Newark, Del.). In addition to the standards obtained from MIDI Corp. (Newark, Del.), quantification standards were obtained from Supelco 37-component fatty acid methyl ester (FAME) mix (Bellefonte, Pa.) and prepared in hexane. FAME samples were separated by using an Agilent 6890 gas chromatograph and identified with the Microbial Identification System (version 4.0) from MIDI Corp.
Amino acid analysis and sequence. Amino acid sequence analysis was performed by Edman degradation with an Applied Biosystems 477A protein sequencer coupled to a 120A analyzer. Sequence analysis was performed on samples electroblotted to polyvinylidene difluoride membranes as described above.
Spectroscopy. Optical absorption spectroscopy and X-band EPR spectra were obtained as previously described (48, 52).
Total RNA extraction from pure cultures. Care was taken in handling RNA to prevent RNA degradation by RNase as described earlier (19). Briefly, RNase activity was removed through oven baking and the use of either RNase-free compounds or diethyl pyrocarbonate (DEPC; Sigma)-treated water, or RNase was treated with DEPC. RNA extractions were performed with the Qiagen Total RNeasy kit (Qiagen, Inc.,Valencia, Calif.), and cells were lysed by bead beating. After being treated with RNase-free DNase I (Promega), total RNA was extracted with the Qiagen Total RNeasy kit.
Homologous internal RNA standards were designed with similar base sequences that could be amplified with the same primers used for target mRNA and for competitive reverse transcription-PCR (RT-PCR) by using the QIAGEN OneStep RT-PCR kit. The RT-PCR was carried out in 50 µl consisting of 5 µl of standard RNA, 5 µl of total RNA, 10 µl of 5x RT-PCR buffer, 10 µl of 5x Q solution, 400 µM (each) deoxynucleoside triphosphates (dNTPs), 0.6 µM each primer, and 2 µl of Qiagen OneStep RT-PCR enzyme. The sequences of steps to reverse transcribe and amplify both targets and standards were as follows. Following an RT incubation at 50°C for 30 min and heating to 95°C for 15 min, 30 PCR cycles with the following amplification profile were conducted: 94°C for 1 min, 55°C for 1 min, and 72°C for 1 min. All samples were finally extended at 72°C for 10 min. PCR products were analyzed quantitatively by capillary electrophoresis on a Beckman P/ACE MDQ instrument (Beckman Instruments, Palo Alto, Calif.).
|
|
|---|
![]() View larger version (26K): [in a new window] |
FIG. 1. Effect of copper concentration in the culture medium on the rates of propylene oxidation in whole-cell ( ), washed membrane ( ), and soluble ( ) fractions. The rate of copper addition was 1.7 µM · h-1, while the cell density was maintained at an OD600 of between 1.8 and 2.0.
|
20 nmol · min-1 · mg of protein) pMMO preparations were obtained in the absence of supplemental iron. Effect of copper in the culture medium on pMMO expression and membrane development. To document the physiological events that occur during growth under these culture conditions, the initial copper concentration in the medium was changed from 5 µM to 0 µM, thus allowing the cells to express sMMO. As the copper concentration was increased in these chemostats, samples were taken periodically and analyzed as follows: (i) by morphology; (ii) by copper concentration in the spent medium, whole-cell, soluble, and membrane fractions; (iii) by propylene oxidation activity in the whole-cell, soluble, and membrane fractions; (iv) by SDS-PAGE of the whole-cell, soluble, and membrane fractions; (v) by immunoblotting with antibodies specific for pMMO and methanol dehydrogenase (MDH), (vi) by transcript levels of the genes encoding polypeptides for both sMMO and pMMO using RT-PCR and capillary electrophoresis; and (vii) by fatty acid concentration via MIDI-FAME analysis. The fatty acid concentration was used as an estimate of phospholipid concentration.
Figure 2 shows copper acquisition in cells cultured under increasing-copper conditions. Under the culture conditions described above, the copper concentration in the spent medium was constant (0.8 ± 0.3 µM) until the copper addition reached 59 µM and then increased at higher concentrations. Of the copper recovered in the spent medium, <4% was associated with the organic fraction (i.e., the cbc fraction in the spent medium). Between 1 and 20 µM amended copper, the copper associated with the whole-cell and membrane fractions increased proportionately with copper addition (Table 1). Between 20 and 60 µM copper addition, the copper concentration in the spent medium remained 0.8 ± 0.3 µM, but there was a less-than-expected increase in copper concentration per milligram of cell or membrane protein (Fig. 2A). Above 60 µM copper, copper accumulated in the spent medium, and the copper concentration per milligram of protein in the whole-cell and membrane fractions decreased. The results were surprising considering the average copper mass balances of the cell fractionation studies were close to 70% (68% ± 12%) and the copper mass balance of the whole-cell (i.e., whole-cell and spent medium fractions) component of the studies was close to 80% (78% ± 16%). The discrepancy between the copper lost from the spent medium and cell-associated copper was resolved when the cell-associated copper was calculated on a per-cell-number basis and not via protein concentration (Fig. 2B). When plotted against cell number, the results show the cell-associated copper increased until the amended copper reached 80 µM. Taken as a whole, the results from Fig. 2 and Table 1 indicate that in cultures with cell densities of 1.9 x 109 ± 0.3 x 109 cells per ml, the cells took up essentially all of the amended copper until the amended copper concentrations exceeded 60 µM. The results also indicate that the affinity of copper acquisition systems in M. capsulatus Bath is
0.5 µM.
![]() View larger version (23K): [in a new window] |
FIG. 2. (A) Copper concentrations associated with the whole-cell fraction ( ) and membrane fraction ( ) of cells cultured in chemostats with increasing copper concentrations. The right-hand axis shows the copper concentration in the spent medium following cell separation ( ). (B) Percent increase in copper per cell ( ) and copper per milligram of whole-cell protein (). Chemostat conditions and cell samplings were as described in the legend to Fig. 1.
|
|
View this table: [in a new window] |
TABLE 1. Bivariate correlations of copper concentration in the culture media to methane oxidation activity and concentrations of copper, pMMO peptide and transcript, and fatty acids per cell
|
![]() View larger version (112K): [in a new window] |
FIG. 3. (I) SDS-PAGE of whole-cell samples from M. capsulatus Bath. Cell samples were taken before the addition of copper (0.3 µM copper) (lane A) and when the copper concentration in the chemostat reached 1 (lane B), 5 (lane C), 15 (lane D), 25 (lane E), 35 (lane F), 45 (lane G), 55 (lane H), 65 (lane I), and 75 (lane I) µM. Molecular mass standards (Invitrogen Mark 12 standards; 200, 116.3, 97.4, 66.3, 55.4, 36.3, 21.5, 14.4, 6, 3.5, and 2.5 kDa) are shown in lane K. Chemostat conditions and cell samplings were as described in the legend to Fig. 1. The cell sample in each lane was standardized to 1.3 x 108 cells per lane. (II) -NT, Coomassie-stained gel illustrating the protein remaining in the 43-kDa region of an SDS-polyacrylamide gel following blotting for 1 h. The Coomassie-stained gel following transfer is included because of the poor transfer of the subunit of the pMMO. (III and IV) Immunoblot analysis of M. capsulatus Bath cell fractions with antibodies against the (III) and ß (IV) subunits of the pMMO and with antibodies against MDH. (V) MDH was used as a non-copper-regulated protein control. Arrows to the left indicate sMMO hydroxylase polypeptides, and those to the right indicate pMMO polypeptides.
|
![]() View larger version (15K): [in a new window] |
FIG. 4. Transcript concentration of pmoA ( ) and mmoX ( ) in M. capsulatus Bath cells cultured in medium not supplemented with copper; expressing sMMO; and following the addition of 1, 5, 25, or 55 µM CuSO4. Chemostat conditions and cell samplings were as described in the legend to Fig. 1.
|
![]() View larger version (169K): [in a new window] |
FIG. 5. Thin-section transmission electron micrograph of M. capsulatus Bath cultured as described in the legend to Fig. 1. Chemostat conditions were as described in the legend to Fig. 1. Cell samples were taken when the added copper concentration in the culture medium reached 5 (A), 20 (B), 40 (C), 60 (D), 80 (E), and 89 (F) µM. Marker bar, 200 nm.
|
![]() View larger version (32K): [in a new window] |
FIG. 6. Effect of copper concentration during growth of M. capsulatus Bath with low (A) and high (B) concentrations of fatty acids. The following fatty acids were monitored: 16:0 3-OH FAME (), 14:0 FAME ( ), 17:0 FAME ( ), 15:0 FAME ( ), 16:0 ( ), 16:1 cis 9 FAME ( ), and 16:1 cis 11 ( ). The chemostat conditions and cell samplings were as described in the legend to Fig. 1.
|
subunit of the pMMO. The 36,000-Da polypeptide was a mixture of a breakdown product of the
subunit of the pMMO and type 2 NADH:quinone oxidoreductase (NDH) (6).
Detergent/protein ratio.
Previous studies on the solubilization of the pMMO using dodecyl ß-D-maltoside focused on the activity in the detergent-solubilized fraction, with an optimal detergent/protein ratio of 1.6 mg of dodecyl ß-D-maltoside per mg of protein (41, 52). With the higher-activity membrane preparations described above, the optimal detergent/protein ratio was reexamined. In contrast to previous studies, the propylene oxidation activity was measured before centrifugation and in the particulate and the detergent-solublized fractions following centrifugation. The results are shown in Fig. 7. Two basic conclusions were obtained from the results of the detergent series. First, the optimal detergent/membrane protein ratio for solublization of propylene oxidation activity was 1 to 1.25 mg of dodecyl ß-D-maltoside per mg of protein. Above 0.3 mg of dodecyl ß-D-maltoside per mg of membrane protein, solubilization of the
ß
polypeptides of the pMMO was proportional and increased with increasing detergent concentrations, with maximal solubilization at 4.6 mg of dodecyl ß-D-maltoside per mg of membrane protein (Fig. 7). However, no activity was observed at detergent/protein ratios above 2.0. Second, both low and high detergent concentrations resulted in the irreversible inactivation of the pMMO. This inactivation was observed within 15 min of detergent addition.
![]() View larger version (53K): [in a new window] |
FIG. 7. (Top) Effect of dodecyl ß-D-maltoside on membrane-associated propylene oxidation activity in M. capsulatus Bath. Shown are the rates of propylene oxidation following incubation in dodecyl ß-D-maltoside for 1 h under anaerobic conditions before ( ) and the soluble fraction after () centrifugation at 150,000 x g for 90 min. (Bottom) SDS-PAGE of solubilized protein (2-µl volume) samples following 150,000 x g centrifugation of washed membrane samples incubated for 1 h with 0.3 (B), 0.5 (C), 0.7 (D), 1.0 (E), 1.4 (F), 1.8 (G), 2.0 (H), 3.0 (I), or 4.0 (J) mg of dodecyl ß-D-maltoside per mg of membrane protein.
|
ß
subunit. In contrast, pMMO isolated following extractions of 1.0, 1.2, 1.4, and 1.6 mg of dodecyl ß-D-maltoside per mg of membrane protein was active and contained 10 to 15 copper atoms and 2 iron atoms per
ß
subunit.
![]() View larger version (19K): [in a new window] |
FIG. 8. Effect of the dodecyl ß-D-maltoside concentration used in the initial solubilization of pMMO on the propylene oxidation activity ( ) and copper ( ) and iron ( ) composition per ß subunit of purified pMMO.
|
0.3 mg of dodecyl ß-D-maltoside per milligram of pMMO, complete enzyme inactivation was observed and the copper atom concentration per pMMO
ß
subunit was approximately 2. The EPR spectra of the purified pMMO sample containing 10 copper atoms before (Fig. 9, trace A) and after (Fig. 9, trace B) the 0.3-mg dodecyl ß-D-maltoside treatment, in which the copper concentration was reduced to 2 copper atoms, were essentially identical. The spectra from both samples showed the type 2 Cu(II) signals associated with the
ß
subunits of the pMMO were present and of similar intensities (2, 23, 25, 48-50, 52). As in previous studies using Triton X-100, the copper dissociated from the
ß
polypeptides, was associated with the cbc (52). Over 70% of the copper atoms bound by cbc are Cu(I) and thus EPR silent (14, 52), which explains the similarities in the spectra before and after detergent treatments.
![]() View larger version (13K): [in a new window] |
FIG. 9. X-band EPR spectra at 77 K of the cupric site in high-detergent-concentration-treated purified active pMMO (79 mU/mg of protein) containing 10 Cu and 2 iron atoms per ß complex (A) and following detergent treatment and containing 2 copper and 2 iron atoms per ß complex (B). The following experimental conditions were used: modulation frequency, 100 kHz; modulation amplitude, 5 G; time constant, 100 ms; microwave frequency, 9.191 GHz; and microwave power, 5.0 mW.
|
![]() View larger version (11K): [in a new window] |
FIG. 10. Inhibition of nitroblue tetrazolium reduction in the presence of Cu-cbc.
|
|
View this table: [in a new window] |
TABLE 2. Purification of pMMO from M. capsulatus Bath using duroquinol, NADH, NADH plus duroquinol or duroquinol alone, NADH, and NDH as the reductantsa
|
![]() View larger version (84K): [in a new window] |
FIG. 11. SDS-PAGE (slab gel) of fractions during the purification of NDH-pMMO complex and of pMMO from M. capsulatus Bath. Lanes: A, whole-cell fraction; B, washed membrane fraction; C, detergent-solubilized fraction (1.2 g of dodecyl ß-D-maltoside per g of membrane protein); D, first DEAE-Sepharose FF eluate; E, second DEAE-Sepharose FF eluate.
|
The purification procedure for pMMO was also modified to copurify pMMO with NDH. In the current purification procedure, the concentration of NDH peptide added to pMMO polypeptides is low, and the NDH activity in the NDH-pMMO complex represents <80% of the pMMO activity. Thus, this fraction still requires the addition of NDH for optimal activity.
|
|
|---|
In addition to growth conditions, the results reported here illustrate the importance of detergent/protein ratios during pMMO solublization and purification. The inactivation of pMMO at detergent/membrane protein ratios of
0.75 and
2.0 apparently resulted from the differential solubilization of the pMMO and Cu-cbc. At detergent/membrane protein ratios of
0.75, the
ß
polypeptides solublized are Cu-cbc free. Detergent/membrane protein ratios of
2.0 result in the dissociation of the
ß
polypeptides and Cu-cbc. The results suggest the minimal metal content for active purified pMMO as described here is 8 to 10 Cu atoms and 2 iron atoms, with 2 Cu and 2 Fe atoms associated with the
ß
polypeptides and 6 to 8 atoms associated with cbc. The stabilizing effect of Cu-cbc on cell-free pMMO activity is probably the result of its superoxide dismutase-like activity. It is possible that this may be a secondary function of the Cu-cbc in vivo, but it may prove important in protecting this oxygen-utilizing enzyme following solublization from the membrane fraction.
This observation differs from those of two recent reports by Basu et al. (2) and Lieberman et al. (25), which presented partially purified and purified preparation of pMMO containing 2 Cu atoms and 1 to 2 Fe atoms per
ß
subunit. The difference in metal composition of the pMMO in these studies and the results reported here appear to be due to the isolation of pMMO with associated Cu-cbc, as reported in this study, and pMMO isolated in the absence of Cu-cbc. If the samples isolated by Basu et al. (2) and Lieberman et al. (25) are Cu-cbc free, the superoxide-dismutase-like activity of the Cu-cbc may be one of the reasons for higher specific activity of the preparations reported in this study.
The nature of the physiological reductant to the pMMO has been a source of controversy. Most of the available data from this and other laboratories indicate that the pMMO is coupled to the electron transport chain at the cytochrome bc1 complex, probably via the quinone (2, 11, 13, 25, 44, 51, 52), although NADH has also been proposed as the electron donor (33). The reports of NADH-driven pMMO activity are probably due to contaminating NDH in pMMO preparations. The NDH-pMMO complex did show activity with NADH as the sole reductant. However, the activity was only 30% of the activity following the addition of duroquinol. Thus, duroquinol-free activity may have resulted from contaminating ubiquinone in pMMO preparations. Trace contamination of the cytochrome bc1 complex has been shown to be a common trace contaminant in pMMO preparations (23, 41). The ability to separate the NDH and methane (as measured by propylene) oxidation activity indicates the findings of previous reports using NADH as a reductant in pMMO assays were probably due to the presence of NDH in these preparations (33).
In summary, the higher-activity pMMO preparations reported here were the result of several modifications to previous purification attempts. Of the parameters examined, the growth conditions appear to be the most critical factor in stabilizing cell-free pMMO activity. For high cell-free activities, the cells should be maintained in log phase throughout the copper and iron addition series. Copper addition is still critical, which not only results in increased pMMO expression but also increases the concentration of Cu-cbc in the membrane fraction. With respect to stabilizing cell-free pMMO activity, Cu-cbc probably serves a secondary function as an oxygen radical scavenger. Finally, the detergent/enzyme ratio is also critical to activity.
Present address: Department of Biochemistry, Beadle Center, University of Nebraska, Lincoln, NE 68588-0664. ![]()
Present address: Dow AgroSciences LLC, Harbor Beach, MI 48810. ![]()
Present address: Department of Chemistry and Biochemistry, Utah State University, Logan, UT 84322-0300. ![]()
|
|
|---|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»